Aytu BioPharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $90.4M | $118.1M | $20.0M |
| FY2025 | $105.2M | $124.2M | $31.0M |
| FY2026 | $69.7M | $105.0M | $26.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $90.4M | $118.1M | $20.0M |
| FY2025 | $105.2M | $124.2M | $31.0M |
| FY2026 | $69.7M | $105.0M | $26.3M |